Diagnos Laboratorium Utama Tbk. vs Media Nusantara Citra Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Media Nusantara Citra Tbk. trades at Rp204 (market cap 3.1T, 38.18M 24h volume). The key difference: Media Nusantara Citra Tbk. is far larger — about 10× Diagnos Laboratorium Utama Tbk.'s market cap, and Media Nusantara Citra Tbk. is more actively traded (38.18M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | MNCN | |
|---|---|---|
Market Cap | 310.75B | 3.1T |
Volume | 963.6K | 38.18M |
Lot | 9.64K | 381.76K |
Turnover | 217.67M | 7.79B |
Average Price | 225.89 | 204.04 |
Value | 217.67M | 7.79B |
Indicative Equilibrium Price | 226 | 204 |
Indicative Equilibrium Volume | 1K | 17.06K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT. Media Nusantara Citra Tbk (the Company) was established based on Deed No. 48 dated June 17, 1997 of H. Parlindungan L. Tobing, SH, notary in Jakarta.
Read more on MNCN →